StonvexLoading…
StonvexStonvexStonvexCore line items from TBBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $141.15M | $116.80M | $99.24M | $86.17M |
Operating Income | $303.04M | $292.16M | $256.77M | $177.91M |
Net Income | $228.21M | $217.54M | $192.30M | $130.21M |
EPS (Diluted) | $4.92 | $4.29 | $3.49 | $2.27 |
Total Assets | $9.35B | $8.73B | $7.71B | $7.90B |
Total Liabilities | $8.66B | $7.94B | $6.90B | $7.21B |
Cash & Equivalents | $112.65M | $570.12M | $1.04B | $888.19M |
Free Cash Flow OCF − CapEx | $257.92M | $204.94M | $174.16M | $114.48M |
Shares Outstanding | 42.36M | 47.31M | 53.20M | 55.69M |